chr19-49016678-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000894.3(LHB):​c.52G>A​(p.Ala18Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00112 in 1,611,654 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0056 ( 5 hom., cov: 31)
Exomes 𝑓: 0.00066 ( 9 hom. )

Consequence

LHB
NM_000894.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.317

Publications

3 publications found
Variant links:
Genes affected
LHB (HGNC:6584): (luteinizing hormone subunit beta) This gene is a member of the glycoprotein hormone beta chain family and encodes the beta subunit of luteinizing hormone (LH). Glycoprotein hormones are heterodimers consisting of a common alpha subunit and an unique beta subunit which confers biological specificity. LH is expressed in the pituitary gland and promotes spermatogenesis and ovulation by stimulating the testes and ovaries to synthesize steroids. The genes for the beta chains of chorionic gonadotropin and for luteinizing hormone are contiguous on chromosome 19q13.3. Mutations in this gene are associated with hypogonadism which is characterized by infertility and pseudohermaphroditism. [provided by RefSeq, Jul 2008]
LHB Gene-Disease associations (from GenCC):
  • hypogonadotropic hypogonadism 23 with or without anosmia
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0048998).
BP6
Variant 19-49016678-C-T is Benign according to our data. Variant chr19-49016678-C-T is described in ClinVar as Benign. ClinVar VariationId is 1224995.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0056 (852/152132) while in subpopulation AFR AF = 0.0193 (800/41420). AF 95% confidence interval is 0.0182. There are 5 homozygotes in GnomAd4. There are 399 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LHBNM_000894.3 linkc.52G>A p.Ala18Thr missense_variant Exon 2 of 3 ENST00000649238.3 NP_000885.1 P01229A0A0F7RQE6
LHBXM_047438832.1 linkc.100G>A p.Ala34Thr missense_variant Exon 1 of 2 XP_047294788.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LHBENST00000649238.3 linkc.52G>A p.Ala18Thr missense_variant Exon 2 of 3 NM_000894.3 ENSP00000497294.2 P01229
LHBENST00000649284.1 linkn.143G>A non_coding_transcript_exon_variant Exon 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.00560
AC:
851
AN:
152014
Hom.:
5
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00162
AC:
407
AN:
250592
AF XY:
0.00130
show subpopulations
Gnomad AFR exome
AF:
0.0226
Gnomad AMR exome
AF:
0.000983
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000354
Gnomad OTH exome
AF:
0.000327
GnomAD4 exome
AF:
0.000658
AC:
960
AN:
1459522
Hom.:
9
Cov.:
142
AF XY:
0.000572
AC XY:
415
AN XY:
726138
show subpopulations
African (AFR)
AF:
0.0218
AC:
727
AN:
33300
American (AMR)
AF:
0.00116
AC:
52
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39696
South Asian (SAS)
AF:
0.0000580
AC:
5
AN:
86176
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53032
Middle Eastern (MID)
AF:
0.000223
AC:
1
AN:
4484
European-Non Finnish (NFE)
AF:
0.0000863
AC:
96
AN:
1111780
Other (OTH)
AF:
0.00130
AC:
78
AN:
60212
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.420
Heterozygous variant carriers
0
58
117
175
234
292
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00560
AC:
852
AN:
152132
Hom.:
5
Cov.:
31
AF XY:
0.00536
AC XY:
399
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.0193
AC:
800
AN:
41420
American (AMR)
AF:
0.00196
AC:
30
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000221
AC:
15
AN:
67992
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.419
Heterozygous variant carriers
0
36
71
107
142
178
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00188
Hom.:
1
ESP6500AA
AF:
0.0207
AC:
91
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00228
AC:
277

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 13, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 11870227) -

Nov 28, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

LHB-related disorder Benign:1
Oct 31, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.74
CADD
Benign
3.6
DANN
Benign
0.90
DEOGEN2
Benign
0.14
T;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.062
N
LIST_S2
Benign
0.36
.;T
MetaRNN
Benign
0.0049
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L;L
PhyloP100
0.32
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.56
N;.
REVEL
Benign
0.043
Sift
Benign
0.32
T;.
Sift4G
Benign
0.60
T;.
Polyphen
0.0020
B;B
Vest4
0.034
MVP
0.38
MPC
0.075
ClinPred
0.00099
T
GERP RS
1.3
PromoterAI
-0.0042
Neutral
Varity_R
0.031
gMVP
0.30
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5030775; hg19: chr19-49519935; COSMIC: COSV55484440; COSMIC: COSV55484440; API